Below is a list of studies that we will either be soon enrolling or that we are currently enrolling for at Mills Clinical Research.
They include studies on and for the following:
- New HIV medications
- People looking to switch HIV medications
- HIV vaccine research
- Male hormone replacement therapy
Interested? Call 310-550-2271 to speak to the study coordinator.
Upcoming Studies for HIV Treatment
Therapeutic Vaccine Study
Janssen: multi-center, randomized, double-blind Phase 1/2a study evaluating safety, efficacy and immunogenicity of two different vaccine regimens and a TLR7 agonist in HIV-1-infected adults who started antiretroviral treatment during acute HIV infection.
This study will look at the safety and effects of 2 vaccines with a type of treatment called “TLR7 Agonist” that helps the immune system fight HIV.